COVID-19 Products Still Vulnerable To Falsification & Diversion
Executive Summary
High demand for genuine COVID-19 products, together with related product shortages, has fueled the proliferation of falsified, substandard and counterfeit vaccines, medicines and diagnostic tests.
You may also be interested in...
Jan Deadline For API QR Codes In India Arrives; Are Local, Chinese Firms Prepared?
Beginning January, packaging on active pharmaceutical ingredients (APIs) made in or imported into India is to bear a QR code, but the Indian industry is unprepared and feels the move isn’t beneficial. With about 70% of the country’s API imports coming from China, questions remain on its implementation too
Proliferation Of Fake COVID-19 Vaccines Driven By Unequal Access
The lack of availability of coronavirus vaccines in many less well off parts of the world is an open invitation to criminals seeking to sell falsified or substandard versions. Many instances of vaccine theft and diversion have also been found.
European Parliament Wants EU-Wide Pull Incentive Scheme For New Antimicrobials
The three major EU institutions are all calling for urgent action to tackle antimicrobial resistance, with the emphasis very much on incentives for the development of novel medicines and a reduction in overall consumption of antibiotics.